CancerVAX
Santa Barbara, US · Founded 2021 · Nevada corporation
CancerVax develops cancer therapeutics using lipid nanoparticle technology in partnership with Cytiva. The company is focused on creating nanoparticle-based treatments for cancer patients.
Founders & leadership
BE
Byron EltonExecutive
Board
CM
Carla MillerBoard director
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 of 2 rounds · 2023
▶$1MraisedOct 2024 · 1 investors · BiotechnologyRule 506(c)
▶$1MraisedOct 2024 · 1 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Carla MillerDirector
- Byron EltonExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $1M
- Minimum investment
- $100K
- First sale
- Oct 2023
- Incorporated
- Corporation, Nevada, 2021
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapImvax35 shared keywordsImvax is a clinical-stage biopharmaceutical company developing personalized immunotherapies aimed at treating solid tumors, including glioblastoma. Its platform draws on autologous, cell-based approaches to target cancer.
Dynavax NASDAQ: DVAX www.dynavax.com23 shared keywordsDynavax is a commercial-stage biopharmaceutical company that develops and commercializes vaccines against infectious diseases using its adjuvant technology. Its products target immunization and infectious disease prevention.
Vaccinex20 shared keywordsVaccinex is a clinical-stage biotechnology company developing pepinemab (VX15/2503), a humanized monoclonal antibody that blocks SEMA4D signaling, in trials for neurological disorders such as Huntington's and Alzheimer's disease and for solid tumors including breast cancer, melanoma, non-small cell lung cancer and head and neck cancer. It also offers a fusion protein and ActivMab antibody discovery technology for incorporating membrane proteins such as GPCRs and ion channels into poxviruses for antibody selection.
Centivax18 shared keywordsCentivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.
Companies competing with CancerVAX for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does CancerVAX do?
- CancerVax develops cancer therapeutics using lipid nanoparticle technology in partnership with Cytiva. The company is focused on creating nanoparticle-based treatments for cancer patients.
- How much funding has CancerVAX raised?
- CancerVAX has disclosed $1M raised across 1 of its 2 known rounds.
- Where is CancerVAX headquartered?
- CancerVAX is headquartered in Santa Barbara, US.